Monica G. Lawrence
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Monica G. Lawrence has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Larry Borish
Division of Asthma, Allergy, and Immunology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia; Department of Microbiology, University of Virginia School of Medicine, Charlottesville, Virginia
9 shared publications- Larry Borish
Division of Asthma, Allergy, and Immunology, Department of Medicine; Department of Microbiology; Beirne Carter Immunology Center, University of Virginia Department of Statistics
3 shared publications W. Gerald Teague
Department of Pediatrics, University of Virginia Health, Charlottesville, Virginia
3 shared publicationsCharlotte Cunningham-Rundles
Division of Allergy and Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York NY
2 shared publicationsJames Patrie
Division of Public Health Sciences, University of Virginia, Charlottesville, Va
2 shared publicationsJames T. Patrie
Division of Biostatistics, Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia
2 shared publications
Latest Publications
- 15 December 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 53 (7) , 816-822
Examination of HLA-DRB1*15–linked Candidate Antigens in Still Disease With and Without Lung Disease and Drug-Associated Immune Reactions
Objective: Lung disease (LD) in systemic juvenile idiopathic arthritis and adult-onset Still disease (Still-LD) is a severe manifestation strongly associated with HLA-DRB1*15 alleles and drug-associated immune reactions (DAIR), including eosinophilia, non–Still disease rashes, and elevated liver function tests. Despite the high morbidity and mortality of these phenomena, pathogenesis remains poorly understood. This study investigates whether Still-LD and DAIR are associated with pathogenic antigens through hypersensitivity reactions to Aspergillus fumigatus , for which HLA-DRB1*15 is a known risk allele, or drug reaction with eosinophilia and systemic symptoms (DRESS), which is frequently associated with human herpesvirus (HHV) reactivation. Methods: Pediatric and adult subjects were drawn from the National Institutes of Health Still disease cohort. Subjects with Still-LD and/or DAIR were identified by chart review. Serum samples were analyzed for anti– A. fumigatus IgE using ImmunoCap assay, and Epstein-Barr virus (EBV), cytomegalovirus (CMV), and HHV 6 (HHV-6) antibodies were analyzed by luciferase immunoprecipitation systems. Subjects were screened for EBV, CMV, and HHV-6 by nucleic acid amplification tests and/or Viral Transcript Usage Sensor (VIRTUS) analysis of whole-blood RNA sequencing data. Results: Fifty-four subjects were included in the study, 11 had LD and DAIR, and 8 had DAIR alone. Thirty-three subjects were tested for anti– A. fumigatus antibodies and all were negative. Forty-nine subjects were tested for CMV, EBV, and HHV-6; 2 were positive for EBV, both of whom did not have Still-LD or DAIR. Conclusion: The absence of anti– A. fumigatus IgE antibodies and detectable herpesvirus nucleic acids in subjects with Still-LD and DAIR does not support a mechanistic association with hypersensitivity to A. fumigatus or with HHV reactivation.
- 15 December 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 53 (7) , 816-822
Examination of HLA-DRB1*15–linked Candidate Antigens in Still Disease With and Without Lung Disease and Drug-Associated Immune Reactions
Objective: Lung disease (LD) in systemic juvenile idiopathic arthritis and adult-onset Still disease (Still-LD) is a severe manifestation strongly associated with HLA-DRB1*15 alleles and drug-associated immune reactions (DAIR), including eosinophilia, non–Still disease rashes, and elevated liver function tests. Despite the high morbidity and mortality of these phenomena, pathogenesis remains poorly understood. This study investigates whether Still-LD and DAIR are associated with pathogenic antigens through hypersensitivity reactions to Aspergillus fumigatus , for which HLA-DRB1*15 is a known risk allele, or drug reaction with eosinophilia and systemic symptoms (DRESS), which is frequently associated with human herpesvirus (HHV) reactivation. Methods: Pediatric and adult subjects were drawn from the National Institutes of Health Still disease cohort. Subjects with Still-LD and/or DAIR were identified by chart review. Serum samples were analyzed for anti– A. fumigatus IgE using ImmunoCap assay, and Epstein-Barr virus (EBV), cytomegalovirus (CMV), and HHV 6 (HHV-6) antibodies were analyzed by luciferase immunoprecipitation systems. Subjects were screened for EBV, CMV, and HHV-6 by nucleic acid amplification tests and/or Viral Transcript Usage Sensor (VIRTUS) analysis of whole-blood RNA sequencing data. Results: Fifty-four subjects were included in the study, 11 had LD and DAIR, and 8 had DAIR alone. Thirty-three subjects were tested for anti– A. fumigatus antibodies and all were negative. Forty-nine subjects were tested for CMV, EBV, and HHV-6; 2 were positive for EBV, both of whom did not have Still-LD or DAIR. Conclusion: The absence of anti– A. fumigatus IgE antibodies and detectable herpesvirus nucleic acids in subjects with Still-LD and DAIR does not support a mechanistic association with hypersensitivity to A. fumigatus or with HHV reactivation.
- 15 December 2024
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 134 (3) , 279-283
Functional testing of humoral immunity in the Prevnar 20 era
- 15 December 2024
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 134 (3) , 279-283
Functional testing of humoral immunity in the Prevnar 20 era
- 25 April 2024
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 133 (2) , 220-222
IgE deficiency is not associated with hypogammaglobulinemia in a large cohort of military recruits
- 25 April 2024
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 133 (2) , 220-222
IgE deficiency is not associated with hypogammaglobulinemia in a large cohort of military recruits
- 30 October 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (2) , 282-287
Disparities in Diagnosis, Access to Specialist Care, and Treatment for Inborn Errors of Immunity
- 30 October 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (2) , 282-287
Disparities in Diagnosis, Access to Specialist Care, and Treatment for Inborn Errors of Immunity
- 12 May 2023
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 43 (6) , 1448-1454
Impaired Response to Polysaccharide Vaccine in Selective IgE Deficiency
Purpose Immunoglobulin E deficiency (IgED) (defined as IgE < 2 IU/mL) is enriched in patients with primary antibody deficiency (PAD). We hypothesized that selective IgED (sIgED) is a more sensitive predictor of the development of PAD than declining IgG, as IgE production typically requires two class switch recombination (CSR) events in contrast to IgG. Thus, the inability of patients with sIgED to mount an appropriate antibody response to a T-cell independent antigen or evidence of aberrant induction of ɛ germ line (ɛGL) or IgE heavy chain (IgEHC) transcripts in vitro would support the concept that sIgED is a biomarker for emerging PAD. Methods We compared pre- and post-polysaccharide vaccination titers in healthy patients with sIgED without a history of recurrent infections or autoimmunity (n = 20) and in healthy controls (HCs) (n = 17). Subsequently, we assessed in vitro induction of εGL and IgEHC transcripts in patients with sIgED and HC (n = 6) in response to IL-4 + CD40L stimulation. Results Thirty percent of patients with sIgED did not have a robust vaccine response compared to 0% of HCs (p = 0.017). Individuals with sIgED with an abnormal vaccine response demonstrated persistent germline mRNA expression in their B-cells at day 5, with lower levels of IgEHC, compared to both HCs and sIgED participants with a normal vaccine response. Conclusion Patients with sIgED are more likely to have abnormal antibody responses to a T cell–independent antigen and may have dysregulated CSR machinery. Following individuals with sIgED longitudinally may be beneficial in the early identification of PAD.
- 12 May 2023
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 43 (6) , 1448-1454
Impaired Response to Polysaccharide Vaccine in Selective IgE Deficiency
Purpose Immunoglobulin E deficiency (IgED) (defined as IgE < 2 IU/mL) is enriched in patients with primary antibody deficiency (PAD). We hypothesized that selective IgED (sIgED) is a more sensitive predictor of the development of PAD than declining IgG, as IgE production typically requires two class switch recombination (CSR) events in contrast to IgG. Thus, the inability of patients with sIgED to mount an appropriate antibody response to a T-cell independent antigen or evidence of aberrant induction of ɛ germ line (ɛGL) or IgE heavy chain (IgEHC) transcripts in vitro would support the concept that sIgED is a biomarker for emerging PAD. Methods We compared pre- and post-polysaccharide vaccination titers in healthy patients with sIgED without a history of recurrent infections or autoimmunity (n = 20) and in healthy controls (HCs) (n = 17). Subsequently, we assessed in vitro induction of εGL and IgEHC transcripts in patients with sIgED and HC (n = 6) in response to IL-4 + CD40L stimulation. Results Thirty percent of patients with sIgED did not have a robust vaccine response compared to 0% of HCs (p = 0.017). Individuals with sIgED with an abnormal vaccine response demonstrated persistent germline mRNA expression in their B-cells at day 5, with lower levels of IgEHC, compared to both HCs and sIgED participants with a normal vaccine response. Conclusion Patients with sIgED are more likely to have abnormal antibody responses to a T cell–independent antigen and may have dysregulated CSR machinery. Following individuals with sIgED longitudinally may be beneficial in the early identification of PAD.
- 1 February 2023
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 130 (5) , 617-621.e1
Further evidence of a type 2 inflammatory signature in chronic obstructive pulmonary disease or emphysema
- 1 February 2023
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 130 (5) , 617-621.e1
Further evidence of a type 2 inflammatory signature in chronic obstructive pulmonary disease or emphysema
- 9 September 2022
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 34 (6) , 589-594
Navigating diagnostic options for inborn errors of immunity in children: a case-based illustration
Purpose of review: In recent years, there has been a dramatic increase in the number of recognized inborn errors of immunity (IEI), many of which present in childhood. This review discusses diagnostic approaches for some of the more common presentations of IEI in childhood. Recent findings: Implementation of newborn screening (NBS) using the T cell receptor excision circle (TREC) assay has led to the timely identification of patients with severe combined immunodeficiency (SCID) as well as both syndromic and nonsyndromic forms of T cell lymphopenia, including DiGeorge syndrome. Improvements in the availability of immunophenotyping assays, genetic testing and advanced diagnostic techniques such as the artificial thymic organoid system can improve diagnostic clarity and impact management plans. Diagnostic improvements in humoral immunodeficiency include development of novel assays to quantify and functionally evaluate polysaccharide vaccine response. Summary: IEI represent a rapidly growing field, particularly in paediatrics. Use of state-of-the-art diagnostic testing can facilitate rapid identification of IEI, hopefully allowing for initiation of prompt treatment and improved patient outcomes.
- 9 September 2022
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 34 (6) , 589-594
Navigating diagnostic options for inborn errors of immunity in children: a case-based illustration
Purpose of review: In recent years, there has been a dramatic increase in the number of recognized inborn errors of immunity (IEI), many of which present in childhood. This review discusses diagnostic approaches for some of the more common presentations of IEI in childhood. Recent findings: Implementation of newborn screening (NBS) using the T cell receptor excision circle (TREC) assay has led to the timely identification of patients with severe combined immunodeficiency (SCID) as well as both syndromic and nonsyndromic forms of T cell lymphopenia, including DiGeorge syndrome. Improvements in the availability of immunophenotyping assays, genetic testing and advanced diagnostic techniques such as the artificial thymic organoid system can improve diagnostic clarity and impact management plans. Diagnostic improvements in humoral immunodeficiency include development of novel assays to quantify and functionally evaluate polysaccharide vaccine response. Summary: IEI represent a rapidly growing field, particularly in paediatrics. Use of state-of-the-art diagnostic testing can facilitate rapid identification of IEI, hopefully allowing for initiation of prompt treatment and improved patient outcomes.
- 6 June 2022
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 129 (5) , 572-578
Specific antibody deficiency: pearls and pitfalls for diagnosis
- 6 June 2022
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 129 (5) , 572-578
Specific antibody deficiency: pearls and pitfalls for diagnosis
- 1 January 2022
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 128 (1) , 53-60.e3
Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils
- 1 January 2022
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 128 (1) , 53-60.e3
Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils